MeSH term
Frequency | Condition_Probility | 3T3 Cells | 5 | 0.0 |
Animals | 16 | 0.0 |
Cells, Cultured | 3 | 0.0 |
DNA, Complementary | 2 | 0.0 |
G(M2) Ganglioside/metabolism | 2 | 22.0 |
Gene Transfer Techniques | 2 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Humans | 44 | 0.0 |
Hydrolysis | 3 | 0.0 |
Mice | 12 | 0.0 |
Research Support, Non-U.S. Gov't | 27 | 0.0 |
Retroviridae/genetics | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Cell Line | 5 | 0.0 |
Dimerization | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Mutation | 7 | 0.0 |
Phenotype | 7 | 0.0 |
Transduction, Genetic | 2 | 0.0 |
beta-N-Acetylhexosaminidase/chemistry/*genetics | 2 | 50.0 |
Alleles | 7 | 0.0 |
Tay-Sachs Disease/genetics | 2 | 50.0 |
DNA Mutational Analysis | 3 | 0.0 |
Heterozygote | 4 | 0.0 |
Jews/*genetics | 2 | 1.0 |
Polymorphism, Genetic | 2 | 0.0 |
beta-N-Acetylhexosaminidase/*genetics | 11 | 57.0 |
Comparative Study | 10 | 0.0 |
DNA Primers | 4 | 0.0 |
*Mutation | 6 | 0.0 |
Polymerase Chain Reaction | 8 | 0.0 |
Polymorphism, Single-Stranded Conformational | 4 | 0.0 |
Base Sequence | 11 | 0.0 |
Fibroblasts/cytology | 2 | 0.0 |
Molecular Sequence Data | 17 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Tay-Sachs Disease/*genetics | 4 | 66.0 |
Child, Preschool | 2 | 0.0 |
English Abstract | 3 | 0.0 |
Female | 14 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Isoenzymes | 2 | 1.0 |
Liver/enzymology | 3 | 0.0 |
Muscle, Skeletal/enzymology | 2 | 4.0 |
Cloning, Molecular | 5 | 0.0 |
Kinetics | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Genetic Markers | 3 | 0.0 |
Species Specificity | 4 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Isoenzymes/metabolism | 2 | 0.0 |
Lysosomes/enzymology | 2 | 3.0 |
beta-N-Acetylhexosaminidase/*metabolism | 2 | 100.0 |
Exons | 6 | 0.0 |
Tay-Sachs Disease/*genetics/metabolism/pathology | 2 | 100.0 |
Disease Models, Animal | 2 | 0.0 |
Lysosomes/*enzymology | 2 | 4.0 |
Male | 12 | 0.0 |
Adult | 5 | 0.0 |
Pedigree | 4 | 0.0 |
Isoenzymes/*genetics | 2 | 0.0 |
Carbohydrate Sequence | 2 | 0.0 |
Restriction Mapping | 3 | 0.0 |
DNA/genetics | 2 | 0.0 |
*Introns | 2 | 0.0 |
*Point Mutation | 2 | 0.0 |
beta-N-Acetylhexosaminidase/blood/*genetics | 3 | 100.0 |
Introns | 3 | 0.0 |
Gene Expression | 2 | 0.0 |
Israel | 2 | 1.0 |
*Jews | 2 | 4.0 |
Gene Frequency | 4 | 0.0 |
Genetic Screening | 3 | 0.0 |
Jews | 3 | 4.0 |
Pregnancy | 3 | 0.0 |
Quebec | 2 | 3.0 |
Chromosome Mapping | 2 | 0.0 |
*DNA Repair | 2 | 0.0 |
*DNA-Binding Proteins | 2 | 0.0 |
*Heterozygote Detection | 2 | 1.0 |
Blotting, Western | 2 | 0.0 |
Infant | 3 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
*Genes, Structural | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Karyotyping | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
